| Name | Title | Contact Details |
|---|---|---|
Gregory Kaether |
Vice President Information Technology | Profile |
Matt Johnson |
Director Of Security | Profile |
Founded in 2006, Afiniti is a world-leading applied artificial intelligence company that uses patented technology to pair customers and contact center agents based on how well they are likely to interact. Afiniti uses a cutting-edge AI solution to identify and predict patterns in human interactions, subsequently using these predictions to optimally pair customers with contact center agents. In most contact centers today, as a customer contacts a company, they are typically routed to the next available agent. Afiniti® Enterprise Behavioral Pairing™ opens up a whole new world of possibilities that lead to better customer interactions by going beyond this sequenced routing system. As agents become free, our AI deploys specialized machine learning techniques to identify agents` unique interaction histories. In parallel, the technology identifies customers` histories and likely intent, in order to predict which customer-agent pairing is most likely to result in a successful outcome. On the back end, Afiniti further leverages AI and machine learning techniques to identify overarching conversational patterns. Its algorithms continually learn and improve, analyzing millions of interactions every day. Afiniti works closely with clients, using these observations to optimize pairings for the particular KPIs that matter most to their business, such as sales, retention, or collections.
We help deploy a broad set of smart grid initiatives such as advanced metering, distribution automation, demand response and distributed energy resources.
Otava is a global provider of secure, compliant hybrid and multi-cloud solutions for service providers.
Authentic4D exposes exaggerated injuries. It is estimated more than $10 billion of carrier payments are made annually attributed to exaggerated injuries. 70% of humans are visual learners but most don’t know how to read a black and white medical imag...
Control Medical Drug Spend